• Title/Summary/Keyword: 유방암 유방절제술

Search Result 72, Processing Time 0.032 seconds

A Comparison of Clinical Outcomes for Breast-conserving Treatment and Mastectomy for Early Breast Cancer (조기 유방암에서 유방보존치료와 유방절제술 치료성적 비교)

  • Noh, Jae-Myoung;Park, Won;Huh, Seung-Jae;Choi, Doo-Ho;Yang, Jung-Hyun;Nam, Seok-Jin;Kim, Jeong-Han;Im, Young-Hyuck;Ahn, Jin-Seok
    • Radiation Oncology Journal
    • /
    • v.26 no.1
    • /
    • pp.10-16
    • /
    • 2008
  • Purpose: To compare the treatment outcomes and to analyze prognostic factors between the use of a breast-conserving treatment(BCT) and a mastectomy for early stage breast cancer. Materials and Methods: We retrospectively reviewed 1,200 patients with pathological stage T1-2N0 breast cancer who received surgery between September 1994 and December 2002 at Samsung Medical Center. We compared the patient characteristics and treatment outcomes between the two treatment groups. Results: Among the 1,174 eligible patients, 601(51.2%) patients received a BCT and the remaining 573(48.8%) patients received a mastectomy. The mastectomy group of patients had significantly more cases with a larger tumor size, multicentricity, extensive intraductal component, and estrogen- and progester-one-receptor negativity. The ten-year overall survival rates(OS) of the BCT and mastectomy groups were 91.96% and 91.01%, respectively(p=0.1274). The ten-year disease-free survival rates(DFS) were 80.48% for the BCT group of patients and 84.95% for the mastectomy group of patients, respectively(p=0.8795). Conclusion: Our study shows some differences in patient characteristics between the two treatment groups. However, these differences did not result in significant survival differences.

Radiation Therapy for Patients with Early-Stage Breast Carcinoma Treated with Breast-Conserving Surgery (조기 유방암에서 유방 보존술후 방사선 치료)

  • Shin, S.O.
    • Journal of Yeungnam Medical Science
    • /
    • v.14 no.2
    • /
    • pp.274-284
    • /
    • 1997
  • 조기 유방암에 대한 바람직한 치료는 유방의 형태를 최대한 보존하면서 악성 종양을 치료하는 것이다. 이러한 목적을 충분히 달성하기 위하여 최대한 조기에 유방암을 진단하고 미용상 종양 절제술에 적합한 환자를 선택하여 절제 범위를 최소화한 유방 보존술을 시행하며 수술 후 유방 전체에 대한 근치적인 방사선 치료를 적절히 시행하면 된다. 여러 연구에서 전통적인 치료법인 근치적 또는 변형 근치적 유방 절제술의 성적과 비교하여 차이가 없으므로 조기 유방암의 치료에는 이상적인 치료법으로 인정된다. 이와 병행하여 액와부 림프절 및 전신적인 재발에 대한 진단 및 예방을 위하여 액와 림프절에 대한 충분한 외과적인 처치와 병리학적인 검사를 시행하여 불필요한 방사선 치료로 인한 부작용을 최소화하여야 한다. 만약 전신적인 치료가 요구되는 경우에는 항암제 및 내분비 요법을 병행하여 재발을 억제해야 유방 보존술의 장점을 살릴 수 있다. 결론적으로 이 치료법이 조기 유방암 환자의 삶의 질을 개선시키면서 최상의 치료 효과를 얻기 위해서는 유관 진료 각과의 의료진이 유기적으로 협조하여 조기 진단률을 높히고, 유방 보존술 및 방사선 치료 과정에서 환자들에게 치료 결과에 대한 확신을 심어주도록 열심히 노력해야 된다. 또한 치료와 연관된 부작용이나 합병증을 최대한 줄여나가는 방향으로 치료 방법을 계속 보완 발전시키는 것이 매우 중요하며 아직도 발전의 여지가 많은 이 치료법이 조기 유방암의 이상적인 치료법으로 정착하기 위해서는 향후 다양한 임상적인 경험을 통한 더 많은 연구가 필요하리라 생각한다.

  • PDF

Radiation Treatment of Postmastectomy Lymphangiosarcoma (유방 철제술후 임파육종의 치료 1예)

  • Choi, Ihl-Bong;Kim, Mi-Hee;Gil, Hak-Jun;Kim, Chun-Yul;Bahk, Yong-Whee
    • Radiation Oncology Journal
    • /
    • v.6 no.1
    • /
    • pp.81-84
    • /
    • 1988
  • Since the entity of postmastectomy lymphangiosarcoma was first reported by Stewart and Treves in 1948, postmastectomy lymphangiosarcoma has become a well recognized, uncommon malignant tumor which occurs in the upper extremity following mastectomy for mammary carcinoma. The postmastectomy lymphangiosarcoma occurred at an average age of 63.9 years and at an average of 10 years and 3 months following mastectomy. The lymphangiosarcoma raised from blood and lymphatic vessel. The histologic appearance has been observed edematous dermiss and dilated lymphatics lining with malignant cells. Most authors recommend radical amputation for treatment, either shoulder disarticulation or forequarter amputation. Other modalities of treatment including radiotherapy were considered as ineffetive. The present report provides a case of the regression of postmastectomy lymphangiosarcoma with chronic lymphedema by external irradiation. Radiation therapy was used as primary therapy. Total tumor dose of 6500 cGy in 9 wks was delivered using 6 MV x-ray and 8 MeV electron.

  • PDF

The Effect of Joint Mobilization with Electrotherapy interventions on External Rotation and Pain in Mastectomy Patients (유방암 절제술 환자의 관절가동술과 전기자극을 융합한 중재가 어깨 가쪽돌림과 통증에 미치는 영향)

  • Kim, Tae-Hyun;Cho, Kyun-Hee;Park, Shin-Jun
    • Journal of Convergence for Information Technology
    • /
    • v.10 no.5
    • /
    • pp.188-197
    • /
    • 2020
  • This study was to investigate the effects of joint mobilization with two different electrotherapy methods on shoulder external rotation range of motion and pain in mastectomy patients. Thirty mastectomy patients were divided into STMG (joint mobilization+pain scrambler therapy, n=15) and TENMG (joint mobilization+transcutaneous electrical nerve stimulation, n=15). The measurements were performed shoulder external rotation range of motion (ROM), pain (VAS). In both groups, there was a significant difference in the shoulder external rotation ROM, pain after intervention (p <.05). STMG was more decrease in VAS score than TENMG (p <.05). There was no significant difference in shoulder external rotation ROM between the two groups. In order to decrease the pain of mastectomy patients, it was confirmed that STMG was more effective than TENMG.. It is thought that a control group is added to confirm various differences, and more subjects are needed.

The Role Of Tumor Marker CA 15-3 in Detection of Breast Cancer Relapse After Curative Mastectomy (유방암 환자에서 근치적 유방 절제술 후 재발 발견에 대한 CA 15-3의 역할)

  • Hyun, In-Young;Kim, In-Ho;Lee, Moon-Hee;Kim, Chul-Soo
    • The Korean Journal of Nuclear Medicine
    • /
    • v.38 no.4
    • /
    • pp.311-317
    • /
    • 2004
  • Purpose: The purpose of this study was to determine the utility of tumor marker CA 15-3 in the following: the diagnosis of breast cancer relapse after curative mastectomy, and the differentiation or the value of tumor marker by site of metastases. Materials and Methods: Two hundred two patients (median age 48 years) with breast cancer included in the follow-up after curative mastectomy. The tumor marker CA 15-3 was determined by IRMA (CIS BIO INTERNATIONAL, France). Test values > 30 U/ml were considered elevated (positive). Results: Among 202 patients, recurrent diseases were found in 16 patients. CA 15-3 was elevated in 5 of 16 patients with recurrences. There was no false-positive patient who had elevated CA 15-3. Sensitivity and specificity of CA 15-3 for detection of breast cancer recurrence were 31%, and 100%. CA 15-3 was elevated in all of the 4 patients with liver metastases. CA 15-3 was elevated in none of the patients who relapsed with metastasis to bone-only or contralateral breast-only. Conclusion: The tumor marker CA 15-3 in the detection of breast cancer relapse after curative mastectomy is specific, but not sensitive. However, it is useful to rule out liver metastases of breast cancer, which indicates bad prognosis.

Radical Radiotherapy with Lumpectomy (wide excisional biopsy) for Early Breast Cancer -A Case Report and Review of Literature- (초기 유방함의 근치적 방사선치료)

  • Oh, Won-Young;Whang, In-Soon
    • Radiation Oncology Journal
    • /
    • v.6 no.2
    • /
    • pp.283-288
    • /
    • 1988
  • However, long-term results of retrospective studies suggest that, for the great majority of individuals, mastectomy or conservative surgery with radiation therapy were be equally effective. The results at 5 and 10 years from prospective randomized trials indicate that survival following primary radiation therapy for early breast cancer is equivalent to that fellowing mastectomy. When competently Performed, Primary radiation therapy gives highly satisfactory cosmetic results and acceptably low rates of local tumor recurrence. A number of controversial issues remain concerning patient evaluation and selection and the optimal techniques of treatment, both surgical and radiotherapeutic. In addition, further work is needed to clearity the best way to integrate primary radiotherapy with adjuvant systemic treatment. And further follow-up of these patients with primary radiation therapy for early beast cancer will be required for ultimate proof of the relative merits. A case which was conservative surgery and radical irradiation of early breast cancer with review of literatures will be done.

  • PDF

A Review on Gynecomastia and Male Breast Cancer for Radiologists (영상의학과 의사들을 위한 여성형 유방과 남성 유방암에 관한 리뷰)

  • Eun Jin Hwang;Joo Hee Cha
    • Journal of the Korean Society of Radiology
    • /
    • v.81 no.5
    • /
    • pp.1096-1108
    • /
    • 2020
  • The most common cause of a palpable mass or asymmetry in male breast is gynecomastia; however, male breast cancer should not be overlooked as a cause, even though it is rare. It is important to know the anatomy and frequency of diseases that affect the male breast, and the differences compared to females, to make an accurate diagnosis and reduce unnecessary examinations and surgical procedures. This review aims to summarize the algorithm of breast exam in symptomatic men, gynecomastia, and breast cancer.

A Systematic Review on Rehabilitation Research for Improving the Range of Motion of Shoulder Joint Motion in Patients with Breast Cancer Resection (유방암 절제술 환자의 어깨 관절가동범위 증진을 위한 재활 연구에 관한 체계적 고찰)

  • Park, Bo-Ra
    • Journal of Convergence for Information Technology
    • /
    • v.10 no.11
    • /
    • pp.257-264
    • /
    • 2020
  • The purpose of this study is to investigate the types and effects of rehabilitation by systematically examining the rehabilitation research for improving the shoulder ROM in breast cancer resection patients. For a systematic review, a total of 8 studies were finally selected through three databases including RISS. As a result of this study, the level of qualitative was 4 studies(50.0%) in level III, and the rehabilitation period varied from 4 weeks to 12 weeks. As for the type of rehabilitation, 3 studies(37.5%) were occupational therapy and physical therapy. The ROM of the shoulder joint was 7 studies(87.5%) of flexion, extension, and external rotation. A goniometer was used in 8 studies(100.0%) to evaluate the ROM of the joint as a measuring tool. This study is expected to provide basic data in the field of convergence when developing and applying interventional protocols for patients with limited ROM due to breast cancer resection.

Postoperative Radiation Therapy in High-risk Breast Cancer (고위험 유방암 환자의 수술 후 방사선치료)

  • Lee Kyung-Ja
    • Radiation Oncology Journal
    • /
    • v.19 no.4
    • /
    • pp.312-318
    • /
    • 2001
  • Purpose : To assess the locoregional recurrence rate, survival rate and prognostic factors after modified radical mastectomy and postoperative adjuvant radiation therapy with or with chemotherapy in high-risk breast cancer patients. Methods : Between $1984\~1995$, 48 patients underwent postoperative irradiation to the regional lymphatics and chest wall due to large tumor size $(\geq5\;cm)$ or small tumor size (<5 cm) with axillary lymph node involvement after modified radical mastectomy. The median age of the patients was 47 years (range, $31\~79\;years$). The clinical tumor size was <2 cm in 1 patient, $2\~5\;cm$ in 15 patients, and >5 cm in 32 patients. Thirty two patients had positive axillary lymph nodes. Forty two patients were irradiated to the chest wall and regional lymph node and 6 patients were irradiated in the chest wall only. Radiation dose to the chest wall and regional lymph node was 5040 cGy/28 fraction. The median follow-up time was 61 months. Results : Locoregional recurrence rate was $8\%$ and distant metastatic rate was $14\%$. The actuarial overall survival rate and disease-free survival rate was $53\%\;and\;62\%$ at 5 years, respectively. The median survival time was 57 months. Five-year overall survival rate by the stage is $70\%$ in IIB and $58\%$ in IIA. The significant prognostic factor for survival on multivariate analysis was the stage. Conclusion : Postoperative adjuvant radiation therapy in high-risk breast cancer can reduce the locoregional recurrence rate and increase the survival time by combined chemotherapy. The significant prognostic factor for survival rate was the stage.

  • PDF

A Study on the Wearing and Manufacturing Condition of Artificial Breast in Breast Cancer Patients with a Mastectomy (유방절제술을 시행한 유방암 환자의 시판 인조유방 착용 및 판매실태)

  • Koo, Da Som;Kim, Youn Joo;Nam, Yun Ja;Seo, Kwan Sik;Lee, Eun Shin;Noh, ong Young
    • Fashion & Textile Research Journal
    • /
    • v.22 no.1
    • /
    • pp.76-86
    • /
    • 2020
  • The study surveyed patients undergoing a mastectomy to understand their experience and requirements on artificial breasts and sales status. We retrieved 149 of the 150 surveyed questionnaires; subsequently, 144 questionnaires, excluding missing values, were used in the analysis. According to the results of the study, about 67% of respondents said that artificial breasts were not used after undergoing a mastectomy, and more than half of the breast cancer patients were not aware of the importance of artificial breasts. Breast cancer patients wearing artificial breast felt uncomfortable and hot during daily activities as well as experienced difficulty in size selection and purchase price burdens. The three most responded brands were selected based on the results of the survey that also investigated the sales status of the commercial artificial breast. Company A was selling artificial breast to reflect the consumer's functional requirements, and Company C was selling artificial breast with various kinds of reduced weight. However, it is thought that consumers will have less choice since artificial breasts have more limited forms than various types. Therefore, it is believed that the patient needs artificial breasts that satisfy the shape of various types of mastectomy. This study can be used as basic data for artificial breast development studies.